{"entity":{"id":"nct07009145","kind":"trial","name":"QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC","aka":[],"tldr":"A phase 2 trial of QL1706 and bevacizumab (glioblastoma use) in colorectal cancer, run by Qianfoshan Hospital, not yet recruiting.","summary":"QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC is a phase 2, interventional study registered as NCT07009145 by Qianfoshan Hospital, with a registry enrolment figure of 22 participants, started 2025-06-27 and due to reach its primary completion in 2026-06-30. Interventions recorded: QL1706; Bevacizumab. Conditions listed: Unresectable Colorectal Cancer; Metastatic Colorectal Cancer (CRC); MSI-H/dMMR Colorectal Cancer. Primary outcome: ORR. Colorectal eligibility wording from the registry: \"* Histologically confirmed unresectable locally advanced or metastatic colorectal cancer\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07009145","url":"https://clinicaltrials.gov/study/NCT07009145"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer","msi-high-colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":["ql1706","bevacizumab-glioma"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07009145","phase":"2","setting":"An Exploratory Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Bevacizumab for the Treatment of Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer","sponsor":"Qianfoshan Hospital","enrolled":22,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07009145/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"msi-high-colorectal","kind":"cancer","name":"Mismatch-repair deficient (MSI-high) colorectal cancer","route":"/cancers/msi-high-colorectal/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"drug":[{"id":"bevacizumab-glioma","kind":"drug","name":"Bevacizumab (glioblastoma use)","route":"/drugs/bevacizumab-glioma/"},{"id":"ql1706","kind":"drug","name":"QL1706","route":"/drugs/ql1706/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}